Cited by 150Mesenchymal stem cell researchMultiple Sclerosis Research StudiesExtracellular vesicles in disease

The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Open access

Staff, Nathan P., Jones, David T., Singer, Wolfgang·2019·Mayo Clinic Proceedings

DOI 10.1016/j.mayocp.2019.01.001PMC PMC6643282

Open this paper in CoChat — free account

Abstract

Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of medical conditions. Over the past decade, there has been considerable excitement about using MSCs to treat neurodegenerative diseases, which are diseases that are typically fatal and without other robust therapies. In this review, we discuss the proposed MSC mechanisms of action in neurodegenerative diseases, which include growth factor secretion, exosome secretion, and attenuation of neuroinflammation. We then provide a summary of preclinical and early clinical work on MSC therapies in amyotrophic lateral sclerosis, multiple system atrophy, Parkinson disease, and Alzheimer disease. Continued rigorous and controlled studies of MSC therapies will be critical in order to establish efficacy and protect patients from possible untoward effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.mayocp.2019.01.001

Cites

193 of 193 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

DJ-1 Modulates α-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70
Batelli, S., Albani, D., Rametta, R., Polito, L., Prato, F., Pesaresi, M., Negro, A., & Forloni, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001884 · Cited by 130
Retracted
Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopamine Neurons Mediated by the Lmx1a and Neurturin In Vitro: Potential Therapeutic Application for Parkinson’s Disease in a Rhesus Monkey Model
Yan, M., Sun, M., Zhou, Y., Wang, W., He, Z., Tang, D., Lu, S., Wang, X., Li, S., Wang, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064000 · Cited by 76
Retracted
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Second consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J., March, K. L., Redl, H., Rubin, J. P., Yoshimura, K., & Gimble, J. M. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.02.006 · Cited by 1,890
Concise review: MSC-derived exosomes for cell-free therapy
Phinney, D. G., & Pittenger, M. F. (2017) · Stem Cells · doi:10.1002/stem.2575 · Cited by 1,834
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury
Islam, M. N., Das, S. R., Emin, M. T., Wei, M., Sun, L., Westphalen, K., Rowlands, D. J., Quadri, S. K., Bhattacharya, S., & Bhattacharya, J. (2012) · Nature Medicine · doi:10.1038/nm.2736 · Cited by 1,585
Transfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
100 years of Lewy pathology
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
Panés, J., García‐Olmo, D., Assche, G. V., Colombel, J., Reinisch, W., Baumgart, D. C., Dignass, A. U., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31203-x · Cited by 1,094
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 945
Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Karussis, D. M., Karageorgiou, C. E., Vaknin‐Dembinsky, A., Kurkalli, B. G., Gomori, J. M., Kassis, I., Bulte, J. W. M., Petrou, P., Ben‐Hur, T., Abramsky, O., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.248 · Cited by 935
Innate immunity in Alzheimer's disease
Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902
A Long-Term Follow-Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke
Lee, J. S., Hong, J. M., Moon, G. J., Lee, P. H., Ahn, Y. H., & Bang, O. Y. (2010) · Stem Cells · doi:10.1002/stem.430 · Cited by 775
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
Ponsen, M. M., Stoffers, D., Booij, J., van Eck‐Smit, B. L. F., Wolters, E. C., & Berendse, H. W. (2004) · Annals of Neurology · doi:10.1002/ana.20160 · Cited by 758
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Moreira, P. I., Carvalho, C., Zhu, X., Smith, M. A., & Perry, G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.006 · Cited by 734
Mesenchymal stem cells avoid allogeneic rejection
Ryan, J. M., Barry, F. P., Murphy, J. M., & Mahon, B. P. (2005) · Journal of Inflammation · doi:10.1186/1476-9255-2-8 · Cited by 714
Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease
Weiss, M. L., Medicetty, S., Bledsoe, A. R., Rachakatla, R. S., Choi, M. S. K., Merchav, S., Luo, Y., Rao, M. S., Velagaleti, G. V. N., & Troyer, D. L. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0330 · Cited by 694
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Connick, P., Kolappan, M., Crawley, C. R., Webber, D. J., Patani, R., Michell, A. W., Du, M., Luan, S., Altmann, D. R., Thompson, A. J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70305-2 · Cited by 611
Cascading network failure across the Alzheimer’s disease spectrum
Jones, D. T., Knopman, D. S., Gunter, J. L., Graff‐Radford, J., Vemuri, P., Boeve, B. F., Petersen, R. C., Weiner, M. W., & Jack, C. R. (2015) · Brain · doi:10.1093/brain/awv338 · Cited by 560
Self-citation
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke
Honmou, O., Houkin, K., Matsunaga, T., Niitsu, Y., Ishiai, S., Onodera, R., Waxman, S. G., & Kocsis, J. D. (2011) · Brain · doi:10.1093/brain/awr063 · Cited by 501
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective
Mendicino, M., Bailey, A. M., Wonnacott, K., Puri, R. K., & Bauer, S. R. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.01.013 · Cited by 500
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
Storkebaum, E., Lambrechts, D., Dewerchin, M. A., Moreno-Murciano, P., Appelmans, S., Oh, H., Damme, P. V., Rutten, B. P. F., Man, W. Y., Mol, M. D., et al. (2004) · Nature Neuroscience · doi:10.1038/nn1360 · Cited by 499
CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
Beers, D. R., Henkel-Tigges, J., Zhao, W., Wang, J., & Appel, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807419105 · Cited by 486
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
Parkinson's--Divergent Causes, Convergent Mechanisms
Greenamyre, J. T., & Hastings, T. G. (2004) · Science · doi:10.1126/science.1098966 · Cited by 457
A controlled trial of recombinant methionyl human BDNF in ALS
The BDNF Study Group (Phase III) (1999) · Neurology · doi:10.1212/wnl.52.7.1427 · Cited by 453
Neuroplasticity Failure in Alzheimer's Disease
Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
Beers, D. R., Henkel-Tigges, J., Zhao, W., Wang, J., Huang, A., Wen, S., Liao, B., & Appel, S. H. (2011) · Brain · doi:10.1093/brain/awr074 · Cited by 439
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy
Glenn, J. D. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.526 · Cited by 418
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke
Steinberg, G. K., Kondziolka, D. S., Wechsler, L. R., Lunsford, L. D., Coburn, M., Billigen, J. B., Kim, A. S., Johnson, J. N., Bates, D., King, B., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.012995 · Cited by 404
Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease
Venkataramana, N. K., Kumar, S. K. V., Balaraju, S., Radhakrishnan, R. C., Bansal, A., Dixit, A., Rao, D. K., Das, M., Jan, M., Gupta, P. K., et al. (2009) · Translational research · doi:10.1016/j.trsl.2009.07.006 · Cited by 403
Arrest of Motor Neuron Disease in wobbler Mice Cotreated with CNTF and BDNF
Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J. M., Wong, V., & Lindsay, R. M. (1994) · Science · doi:10.1126/science.8066451 · Cited by 386
Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filaments
El‐Agnaf, O. M. A., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01418-5 · Cited by 368
Targeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24304 · Cited by 358
The role of α-synuclein in Parkinson's disease: insights from animal models
Lad, E. M., Dass, B., Collier, T. J., Kordower, J. H., & Steece‐Collier, K. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1199 · Cited by 357
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Benatar, M. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.015 · Cited by 352
Alzheimer’s disease, dementia, and stem cell therapy
Duncan, T., & Valenzuela, M. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0567-5 · Cited by 347
A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis
Miller, R. G., Petajan, J. H., Bryan, W. W., Armon, C., Barohn, R. J., Goodpasture, J. C., Hoagland, R. J., Parry, G. J., Ross, M. A., Stromatt, S. C., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390215 · Cited by 346
Amyotrophic Lateral Sclerosis: An Update for 2018
Oskarsson, B., Gendron, T. F., & Staff, N. P. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.007 · Cited by 338
Self-citation
Natural history of multiple system atrophy in the USA: a prospective cohort study
Low, P. A., Reich, S. G., Jankovic, J. J., Shults, C. W., Stern, M. B., Novák, P., Tanner, C. M., Gilman, S., Marshall, F. J., Wooten, F. G., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00058-7 · Cited by 337
Self-citation
Autophagy and Alzheimer’s Disease
Li, Q., Liu, Y., & Sun, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0386-8 · Cited by 337
Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
Murray, M. E., Lowe, V. J., Graff-Radford, N. R., Liesinger, A. M., Cannon, A., Przybelski, S. A., Rawal, B., Parisi, J. E., Petersen, R. C., Kantarci, K., et al. (2015) · Brain · doi:10.1093/brain/awv050 · Cited by 324
Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)
Zhang, R., Miller, R. G., Gascon, R., Champion, S., Katz, J., Lancero, M., Narvaez, A., Honrada, R., Ruvalcaba, D., & McGrath, M. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.017 · Cited by 319
Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., Tajti, J., & Appel, S. H. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540010026013 · Cited by 318
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis
Vercelli, A., Mereuta, O., Garbossa, D., Muraca, G., Mareschi, K., Rustichelli, D., Ferrero, I., Mazzini, L., Madon, E., & Fagioli, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.016 · Cited by 310
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Zhao, W., Beers, D. R., & Appel, S. H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9489-x · Cited by 309
Exosomes Derived from Mesenchymal Stromal Cells Promote Axonal Growth of Cortical Neurons
Zhang, Y., Chopp, M., Liu, X., Katakowski, M., Wang, X., Tian, X., Wu, D., & Zhang, Z. G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9851-0 · Cited by 308
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis
Petrou, P., Gothelf, Y., Argov, Z., Gotkine, M., Levy, Y. S., Kassis, I., Vaknin‐Dembinsky, A., Ben‐Hur, T., Offen, D., Abramsky, O., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4321 · Cited by 304
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302
MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells
Eirin, A., Riester, S. M., Zhu, X. Y., Tang, H. R., Evans, J. M., O’Brien, D. R., van Wijnen, A. J., & Lerman, L. O. (2014) · Gene · doi:10.1016/j.gene.2014.08.041 · Cited by 298
Widespread Alterations of α-Synuclein in Multiple System Atrophy
Dickson, D. W., Liu, W.-K., Hardy, J., Farrer, M. J., Mehta, N. D., Uitti, R. J., Mark, M. H., Zimmerman, T., Golbe, L. I., Sage, J., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65226-1 · Cited by 298
Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation
Ohta, M., Suzuki, Y., Noda, T., Ejiri, Y., Dezawa, M., Kataoka, K., Chou, H., Ishikawa, N., Matsumoto, N., Iwashita, Y., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.021 · Cited by 292
Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation
Lee, H. J., Lee, J. K., Lee, H.-W., Carter, J., Chang, J. W., Oh, W., Yang, Y. S., Suh, J., Lee, B., Jin, H. K., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.024 · Cited by 291
Clear up this stem-cell mess
Sipp, D., Robey, P. G., & Turner, L. G. (2018) · Nature · doi:10.1038/d41586-018-06756-9 · Cited by 286
Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Li, Y., Chen, J., Wang, L., Zhang, L., Lü, M., & Chopp, M. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02384-9 · Cited by 271
Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory action
Kim, Y., Park, H., Lee, G., Bang, O. Y., Ahn, Y. H., Joe, E.-H., Kim, H. O., & Lee, P. H. (2008) · Glia · doi:10.1002/glia.20731 · Cited by 251
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
Sorenson, E. J., Windbank, A. J., Mandrekar, J. N., Bamlet, W. R., Appel, S. H., Armon, C., Barkhaus, P. E., Bosch, P., Boylan, K., David, W. S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000335970.78664.36 · Cited by 244
Expanding the spectrum of neuronal pathology in multiple system atrophy
Cykowski, M. D., Coon, E. A., Powell, S. Z., Jenkins, S. M., Benarroch, E. E., Low, P. A., Schmeichel, A. M., & Parisi, J. E. (2015) · Brain · doi:10.1093/brain/awv114 · Cited by 241
A randomized trial of mesenchymal stem cells in multiple system atrophy
Lee, P. H., Lee, J. E., Kim, H., Song, S., Lee, H. S., Nam, H. S., Cheong, J., Jeong, Y., Park, H., Kim, D. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23612 · Cited by 233
Microglial activation mediates neurodegeneration related to oligodendroglial α‐synucleinopathy: Implications for multiple system atrophy
Stefanova, N., Reindl, M., Neumann, M., Kahle, P. J., Poewe, W. H., & Wenning, G. K. (2007) · Movement Disorders · doi:10.1002/mds.21671 · Cited by 222
IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221
Autologous Mesenchymal Stem Cell Therapy Delays the Progression of Neurological Deficits in Patients With Multiple System Atrophy
Lee, P. H., Kim, J., Bang, O., Ahn, Y., Joo, I., & Huh, K. H. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100386 · Cited by 217
Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes
Nakano, M., Nagaishi, K., Konari, N., Saito, Y., Chikenji, T., Mizue, Y., & Fujimiya, M. (2016) · Scientific Reports · doi:10.1038/srep24805 · Cited by 216
Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression
Murdock, B. J., Zhou, T., Kashlan, S. R., Little, R. J. A., Goutman, S. A., & Feldman, E. L. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2255 · Cited by 212
Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease
Teixeira, F. G., Carvalho, M. M., Panchalingam, K. M., Rodrigues, A. J., Mendes-Pinheiro, B., Anjo, S. I., Manadas, B. J., Behie, L. A., Sousa, N., & Salgado, A. J. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2016-0071 · Cited by 211
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
Beers, D. R., Zhao, W., Liao, B., Kano, O., Wang, J., Huang, A., Appel, S. H., & Henkel-Tigges, J. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.008 · Cited by 207
Mesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth
Lopez‐Verrilli, M. A., Caviedes, A., Cabrera, A. J. H., Sandoval, S., Wyneken, Ú., & Khoury, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.061 · Cited by 207
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study
Mazzini, L., Mareschi, K., Ferrero, I., Miglioretti, M., Stecco, A., Servo, S., Carriero, A., Monaco, F., & Fagioli, F. (2011) · Cytotherapy · doi:10.3109/14653249.2011.613929 · Cited by 205
Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss
Annerino, D. M., Arshad, S., Taylor, G. M., Adler, C. H., Beach, T. G., & Greene, J. G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1040-2 · Cited by 204
The paradox of syndromic diversity in Alzheimer disease
Warren, J. D., Fletcher, P. D., & Golden, H. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.135 · Cited by 204
Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis
Bonafede, R., Scambi, I., Peroni, D., Potrich, V., Boschi, F., Benati, D., Bonetti, B., & Mariotti, R. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.12.009 · Cited by 201
Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process
Mantovani, S., Garbelli, S., Pasini, A., Alimonti, D., Perotti, C. G., Melazzini, M. G., Bendotti, C., & Mora, G. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.012 · Cited by 190
Lewy pathology and neurodegeneration in premotor Parkinson's disease
Tredici, K. D., & Braak, H. (2012) · Movement Disorders · doi:10.1002/mds.24921 · Cited by 187
Migration of Mesenchymal Stem Cells Through Cerebrospinal Fluid into Injured Spinal Cord Tissue
Satake, K., Lou, J., & Lenke, L. G. (2004) · Spine · doi:10.1097/01.brs.0000138273.02820.0a · Cited by 186
Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease
Park, H. J., Lee, P. H., Bang, O. Y., Lee, G., & Ahn, Y. H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05589.x · Cited by 185
Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis
Oh, K., Moon, C., Kim, S. H., Oh, S., Park, J., Lee, J. H., Chang, I. Y., Kim, K. S., & Kim, S. H. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0212 · Cited by 181
Microglial Activation Parallels System Degeneration in Multiple System Atrophy
Ishizawa, K., Komori, T., Sasaki, S., Arai, N., Mizutani, T., & Hirose, T. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.43 · Cited by 172
Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat
Jin, K., Sun, Y., Xie, L., Mao, X. O., Childs, J., Peel, A. L., Logvinova, A. V., Banwait, S., & Greenberg, D. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.010 · Cited by 167
Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model
Yang, H., Xie, Z., Wei, L. F., Yang, H. N., Yang, S. N., Zhu, Z., Wang, P., Zhao, C., & Bi, J. Z. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt227 · Cited by 167
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease
Bouchez, G., Sensebé, L., Vourc’h, P., Garreau, L., Bodard, S., Rico, A., Guilloteau, D., Charbord, P., Besnard, J., & Chalon, S. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.02.003 · Cited by 163
Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1α
Wang, F., Yasuhara, T., Shingo, T., Kameda, M., Tajiri, N., Yuan, W. J., Kondo, A., Kadota, T., Baba, T., Tayra, J. T., et al. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-52 · Cited by 163
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis
Uccelli, A., Milanese, M., Principato, M. C., Morando, S., Bonifacino, T., Vergani, L., Giunti, D., Voci, A., Carminati, E., Giribaldi, F., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00498 · Cited by 160
Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells
Eirin, A., Zhu, X.-Y., Puranik, A. S., Woollard, J. R., Tang, H., Dasari, S., Lerman, A., van Wijnen, A. J., & Lerman, L. O. (2016) · Scientific Reports · doi:10.1038/srep36120 · Cited by 159
Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS)
Zhang, R., Gascon, R., Miller, R. G., Gelinas, D. F., Mass, J., Hadlock, K. G., Jin, X., Reis, J., Narvaez, A., & McGrath, M. S. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.009 · Cited by 158
Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model
Oh, S. H., Kim, H. N., Park, H.-J., Shin, J. Y., & Lee, P. H. (2014) · Cell Transplantation · doi:10.3727/096368914x679237 · Cited by 156
Intranasal Delivery of Bone Marrow-Derived Mesenchymal Stem Cells, Macrophages, and Microglia to the Brain in Mouse Models of Alzheimer's and Parkinson's Disease
Danielyan, L., Beer‐Hammer, S., Stolzing, A., Schäfer, R., Siegel, G., Fabian, C., Kahle, P. J., Biedermann, T., Lourhmati, A., Buadze, M., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x684970 · Cited by 153
Protective Effects of Neurotrophic Factor–Secreting Cells in a 6-OHDA Rat Model of Parkinson Disease
Sadan, O., Bahat-Stromza, M., Barhum, Y., Levy, Y. S., Pisnevsky, A., Peretz, H., Ilan, A. B., Bulvik, S., Shemesh, N., Krepel, D., et al. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0411 · Cited by 152
Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease
Cova, L., Armentero, M., Zennaro, E., Calzarossa, C., Bossolasco, P., Busca, G. A., Deliliers, G. L., Polli, E. E., Nappi, G., Silani, V., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.041 · Cited by 152
Clinical features and autonomic testing predict survival in multiple system atrophy
Coon, E. A., Sletten, D. M., Suarez, M. D., Mandrekar, J. N., Ahlskog, J. E., Bower, J. H., Matsumoto, J. Y., Silber, M. H., Benarroch, E. E., Fealey, R. D., et al. (2015) · Brain · doi:10.1093/brain/awv274 · Cited by 150
Self-citation
Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model
Marconi, S., Bonaconsa, M., Scambi, I., Squintani, G. M., Rui, W., Turano, E., Ungaro, D., D’Agostino, S., Barbieri, F., Angiari, S., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.034 · Cited by 148
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Ubhi, K., Rockenstein, E., Mante, M., Inglis, C., Adame, A., Patrick, C., Whitney, K., & Masliah, E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0567-10.2010 · Cited by 147
Cellular pathology in multiple system atrophy
Wakabayashi, K., & Takahashi, H. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00713.x · Cited by 147
Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells
Nardo, G., Pozzi, S., Pignataro, M., Lauranzano, E., Spano, G., Garbelli, S., Mantovani, S., Marinou, K., Papetti, L., Monteforte, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025545 · Cited by 144
Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice
Kim, H., Kim, H. Y., Choi, M., Hwang, S., Nam, K., Kim, H.-C., Han, J. S., Kim, K. S., Yoon, H. S., & Kim, S. H. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.074 · Cited by 142
Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology
Asahina, M., Vichayanrat, E., Low, D. A., Iodice, V., & Mathias, C. J. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303135 · Cited by 139
Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor
Winkler, J., Ramirez, G. A., Kuhn, H. G., Peterson, D. A., Day-Lollini, P. A., Stewart, G. R., Tuszynski, M. H., Gage, F. H., & Thal, L. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410114 · Cited by 138
Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
Oh, K., Noh, M., Kwon, M., Kim, H. Y., Oh, S., Park, J., Kim, H., Ki, C., & Kim, S. H. (2018) · Annals of Neurology · doi:10.1002/ana.25302 · Cited by 138
Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG)
Geser, F., Wenning, G. K., Seppi, K., Stampfer‐Kountchev, M., Scherfler, C., Sawires, M., Frick, C., Ndayisaba, J., Ulmer, H., Pellecchia, M. T., et al. (2005) · Movement Disorders · doi:10.1002/mds.20678 · Cited by 135
Improving the Post-Stroke Therapeutic Potency of Mesenchymal Multipotent Stromal Cells by Cocultivation With Cortical Neurons: The Role of Crosstalk Between Cells
Babenko, V. A., Silachev, D. N., Zorova, L. D., Pevzner, I. B., Khutornenko, A. A., Plotnikov, E. Y., Sukhikh, G. T., & Zorov, D. B. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0010 · Cited by 135
A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis
Felice, B. D., Guida, M., Guida, M., Coppola, C., Mieri, G. D., & Cotrufo, R. (2012) · Gene · doi:10.1016/j.gene.2012.07.058 · Cited by 133
Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS
Staff, N. P., Madigan, N. N., Morris, J. M., Jentoft, M. E., Sorenson, E. J., Butler, G. W., Gastineau, D. A., Dietz, A. B., & Windebank, A. J. (2016) · Neurology · doi:10.1212/wnl.0000000000003359 · Cited by 123
Self-citation
Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration
Bosch, L. V. D., Storkebaum, E., Vleminckx, V., Moons, L., Vanopdenbosch, L. J., Scheveneels, W., Carmeliet, P., & Robberecht, W. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.004 · Cited by 121
VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson’s disease
Xiong, N., Zhang, Z., Huang, J., Chen, C., Zhang, Z., Jia, M., Xiong, J., Liu, X., Wang, F., Cao, X., et al. (2010) · Gene Therapy · doi:10.1038/gt.2010.152 · Cited by 121
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease
Levy, Y. S., Bahat-Stromza, M., Barzilay, R., Burshtein, A., Bulvik, S., Barhum, Y., Panet, H., Melamed, E., & Offen, D. (2008) · Cytotherapy · doi:10.1080/14653240802021330 · Cited by 119
Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS
Li, W., Brakefield, D., Pan, Y., Hunter, D., Myckatyn, T. M., & Parsadanian, A. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.028 · Cited by 117
Effect of systemic transplantation of bone marrow‐derived mesenchymal stem cells on neuropathology markers in APP / PS 1 Alzheimer mice
Naaldijk, Y., Jäger, C., Fabian, C., Leovsky, C., Blüher, A., Rudolph, L., Hinze, A., & Stolzing, A. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12319 · Cited by 117
Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice
Zhao, C.-P., Zhang, C., Zhou, S., Xie, Y.-M., Wang, Y.-H., Huang, H., Shang, Y., Li, W.-Y., Zhou, C., Yu, M., et al. (2007) · Cytotherapy · doi:10.1080/14653240701376413 · Cited by 116
miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients
Felice, B. D., Annunziata, A., Fiorentino, G., Borra, M., Biffali, E., Coppola, C., Cotrufo, R., Brettschneider, J., Giordana, M. L., Dalmay, T., et al. (2014) · Neurogenetics · doi:10.1007/s10048-014-0420-2 · Cited by 111
SUBCUTANEOUS IGF-1 IS NOT BENEFICIAL IN 2-YEAR ALS TRIAL
Howe, C. L., Bergstrom, R. A., & Horazdovsky, B. F. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b26ae6 · Cited by 108
Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis
Nagano, I., Shiote, M., Murakami, T., Kamada, H., Hamakawa, Y., Matsubara, E., Yokoyama, M., Morita, K., Shoji, M., & Abe, K. (2005) · Neurological Research · doi:10.1179/016164105x39860 · Cited by 107
Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Wrage, P. C., Keefer, E. W., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.011 · Cited by 104
Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis
Boucherie, C., Schäfer, S., Lavand'homme, P. M., Maloteaux, J., & Hermans, E. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22038 · Cited by 100
Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson’s Disease: A Pilot Clinical Study
Venkataramana, N. K., Pal, R., Rao, S. A. V., Naik, A. L., Jan, M., Nair, R., Sanjeev, C., Kamble, R. B., Murthy, D. P., & Chaitanya, K. (2012) · Stem Cells International · doi:10.1155/2012/931902 · Cited by 98
The clinical features of Parkinson's disease in 100 histologically proven cases.
Aj, H., Daniel, S. E., & Aj, L. (1993) · PubMed · Cited by 98
Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease
Lu, L., Zhao, C., Liu, Y., Sun, X., Duan, C., Ji, M. K., Zhao, H., Xu, Q., & Yang, H. (2005) · Brain Research Protocols · doi:10.1016/j.brainresprot.2005.03.002 · Cited by 93
Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALS
Forostyak, S., Homola, A., Turnovcová, K., Svítil, P., Jendelová, P., & Syková, E. (2014) · Stem Cells · doi:10.1002/stem.1812 · Cited by 92
Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis
Boido, M., Piras, A., Valsecchi, V., Spigolon, G., Mareschi, K., Ferrero, I., Vizzini, A., Temi, S., Mazzini, L., Fagioli, F., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.02.003 · Cited by 91
Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection
Stemberger, S., Jamnig, A., Stefanova, N., Lepperdinger, G., Reindl, M., & Wenning, G. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019808 · Cited by 91
Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis
Gustafson, M. P., Staff, N. P., Bornschlegl, S., Butler, G. W., Maas, M. L., Kazamel, M., Zubair, A. S., Gastineau, D. A., Windebank, A. J., & Dietz, A. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182002 · Cited by 89
Self-citation
GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson’s disease
Hoban, D. B., Howard, L., & Dowd, E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.014 · Cited by 86
Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy
Benarroch, E. E., Schmeichel, A. M., & Parisi, J. E. (2002) · Neurology · doi:10.1212/wnl.59.6.944 · Cited by 84
Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo
Mennini, T., Paola, M. D., Bigini, P., Mastrotto, C., Fumagalli, E. R., Barbera, S., Mengozzi, M., Viviani, B., Corsini, E., Marinovich, M., et al. (2006) · Molecular Medicine · doi:10.2119/2006-00045.mennini · Cited by 84
Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain
Moloney, T. C., Rooney, G. E., Barry, F., Howard, L., & Dowd, E. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.040 · Cited by 82
Bone Marrow-Derived Mesenchymal Stem Cells Contribute to the Reduction of Amyloid-β Deposits and the Improvement of Synaptic Transmission in a Mouse Model of Pre-Dementia Alzheimer’s Disease
Bae, J., Jin, H. K., Lee, J. K., Richardson, J. C., & Carter, J. E. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990027 · Cited by 78
Glial cell line‐derived neurotrophic factor–secreting genetically modified human bone marrow‐derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
Glavaski‐Joksimovic, A., Virág, T., Mangatu, T. A., McGrogan, M. P., Wang, X. S., & Bohn, M. C. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22435 · Cited by 77
Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells
Boome, L. C. J. T., Mansilla, C., van der Wagen, L. E., Lindemans, C. A., Petersen, E. J., Spierings, E., Thus, K. A., Westinga, K., Plantinga, M., Bierings, M., et al. (2015) · Leukemia · doi:10.1038/leu.2015.89 · Cited by 76
Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of parkinson’s disease-lessons from transgenic mice
Machado, V., Zöller, T., Attaai, A., & Spittau, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020151 · Cited by 76
Cardiac denervation in patients with Parkinson disease.
Goldstein, D. S. (2007) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.74.suppl_1.s91 · Cited by 72
Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects
Cerri, S., Greco, R., Levandis, G., Ghezzi, C., Mangione, A. S., Armentero, M., Bonizzi, A., Avanzini, M. A., Maccario, R., & Blandini, F. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0023 · Cited by 72
Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
Björklund, A., & Lindvall, O. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-179002 · Cited by 72
Mesenchymal Stem Cells Augment Neurogenesis in the Subventricular Zone and Enhance Differentiation of Neural Precursor Cells into Dopaminergic Neurons in the Substantia Nigra of a Parkinsonian Model
Park, H.-J., Shin, J. Y., Lee, B. R., Kim, H. O., & Lee, P. H. (2012) · Cell Transplantation · doi:10.3727/096368912x640556 · Cited by 69
Adipose-Derived Human Mesenchymal Stem Cells Induce Long-Term Neurogenic and Anti-Inflammatory Effects and Improve Cognitive but not Motor Performance in a Rat Model of Parkinson's Disease
Schwerk, A. M. K., Altschüler, J., Roch, M., Gossen, M., Winter, C., Berg, J., Kurtz, A., Akyüz, L., & Steiner, B. (2015) · Regenerative Medicine · doi:10.2217/rme.15.17 · Cited by 66
Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease
Choi, H. S., Kim, H. J., Oh, J. H., Park, H.-G., Ra, J. C., Chang, K., & Suh, Y. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.022 · Cited by 64
A Potential Role for B-Cell Activating Factor in the Pathogenesis of Autoimmune Myasthenia Gravis
Ragheb, S., Lisak, R. P., Lewis, R. A., Stavern, G. P. V., Gonzales, F., & Simon, K. W. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1358 · Cited by 64
Magnetic targeting of bone marrow stromal cells into spinal cord: through cerebrospinal fluid
Nishida, K., Tanaka, N., Nakanishi, K., Kamei, N., Hamasaki, T., Yanada, S., Mochizuki, Y., & Ochi, M. (2006) · Neuroreport · doi:10.1097/01.wnr.0000227993.07799.a2 · Cited by 64
Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis
Forostyak, S., Jendelová, P., Kapcalová, M., Toro, D. A., & Syková, E. (2011) · Cytotherapy · doi:10.3109/14653249.2011.592521 · Cited by 64
Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Amyloid β-Induced Memory Impairment and Apoptosis by Inhibiting Neuronal Cell Death
Lee, J. K., Jin, H. K., & Bae, J. (2010) · Current Alzheimer Research · doi:10.2174/156720510792231739 · Cited by 63
Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson’s disease
Offen, D., Barhum, Y., Levy, Y.-S., Burshtein, A., Panet, H., Cherlow, T., & Melamed, E. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_16 · Cited by 62
Neuroprotective Effect of Human Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy Parkinsonism
Park, H.-J., Bang, G., Lee, B. R., Kim, H. O., & Lee, P. H. (2010) · Cell Transplantation · doi:10.3727/096368910x540630 · Cited by 62
Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease
Chen, D., Fu, W., Zhuang, W., Lv, C., Li, F., & Wang, X. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23879 · Cited by 61
Dementia: Diagnosis and Evaluation
Fleming, K. C., Adams, A. C., & Petersen, R. C. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.11.1093 · Cited by 55
Distant Mesenchymal Progenitors Contribute to Skin Wound Healing and Produce Collagen: Evidence from a Murine Fetal Microchimerism Model
Seppanen, E. J., Roy, E., Ellis, R., Bou–Gharios, G., Fisk, N. M., & Khosrotehrani, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062662 · Cited by 55
Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor
Whone, A. L., Kemp, K. C., Sun, M., Wilkins, A., & Scolding, N. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.038 · Cited by 54
Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning
Schwerk, A. M. K., Altschüler, J., Roch, M., Gossen, M., Winter, C., Berg, J., Kurtz, A., & Steiner, B. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.09.005 · Cited by 53
Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease
Ye, M., Wang, X., Zhang, Y., Lü, G., Liang, L., Jie-yi, X., & Chen, S. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.07.013 · Cited by 53
Stem Cell Therapy Ameliorates Bladder Dysfunction in an Animal Model of Parkinson Disease
Soler, R., Füllhase, C., Hanson, A. D., Campeau, L., dos Santos, C. C., & Andersson, K. (2012) · The Journal of Urology · doi:10.1016/j.juro.2011.11.079 · Cited by 52
Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.
Xiong, N., Cao, X.-B., Zhang, Z.-T., Huang, J.-S., Chen, C.-N., Zhang, Z.-W., Jia, M., Xiong, J., Liang, Z.-H., Sun, S.-G., et al. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.06.004 · Cited by 51
Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy
Benarroch, E. E. (2006) · Brain · doi:10.1093/brain/awl109 · Cited by 51
Safety of repeated transplantations of neurotrophic factors‐secreting human mesenchymal stromal stem cells
Gothelf, Y., Abramov, N., Harel, A., & Offen, D. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-21 · Cited by 47
Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease
Shetty, P., Ravindran, G., Sarang, S. A., Thakur, A., Rao, H. S., & Viswanathan, C. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.05.002 · Cited by 46
LIF (AM424), a promising growth factor for the treatment of ALS.
Kurek, J., Radford, A., Crump, D., Bower, J., Feeney, S. J., Austin, L., & Byrne, E. (1998) · Journal of Neurological Sciences · doi:10.1016/s0022-510x(98)00208-1 · Cited by 45
Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model
Shetty, P., Thakur, A. M., & Viswanathan, C. (2013) · Cell Biology International · doi:10.1002/cbin.10029 · Cited by 44
Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis
Fontanilla, C. V., Gu, H., Liu, Q., Zhu, T. Z., Zhou, C., Johnstone, B. H., March, K. L., Pascuzzi, R. M., Farlow, M. R., & Du, Y. (2015) · Scientific Reports · doi:10.1038/srep16953 · Cited by 44
GDNF gene delivery via the p75NTR receptor rescues injured motor neurons
Barati, S., Hurtado, P. R., Zhang, S., TINSLEY, R., Ferguson, I. T., & Rush, R. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.027 · Cited by 43
Recovery of behavioral symptoms in hemi-parkinsonian rhesus monkeys through combined gene and stem cell therapy
Zhou, Y., Sun, M., Li, H., Yan, M., He, Z., Wang, W., Wang, W., & Lu, S. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.01.007 · Cited by 42
Blood–brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy
Song, S., Lee, S., Lee, J. J., Lee, J. E., Choi, H. S., Sohn, Y. H., & Lee, P. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.017 · Cited by 41
Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease
Kang, E., Lee, Y. M., Kim, M.-J., Lee, Y.-M., Kumar, B. M., Jeon, B.-G., Ock, S., Kim, H. J., & Rho, G. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.504 · Cited by 39
The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease
Richards, R. I., Robertson, S. A., O’Keefe, L. V., Fornarino, D. L., Scott, A., Lardelli, M. T., & Baune, B. T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00193 · Cited by 39
Gene therapy for ALS delivers
Boillée, S., & Cleveland, D. W. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.002 · Cited by 38
Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson's disease
Mathieu, P., Roca, V., Gamba, C., del Pozo, A., & Pitossi, F. J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.03.004 · Cited by 38
Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression
Saleh, I. A., Zesiewicz, T., Xie, Y., Sullivan, K. L., Miller, A. M., Kuzmin‐Nichols, N., Sanberg, P. R., & Garbuzova-Davis, S. N. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.011 · Cited by 36
Opposite Effects of Bone Marrow-Derived Cells Transplantation in MPTP-rat Model of Parkinson's Disease: A Comparison Study of Mononuclear and Mesenchymal Stem Cells
Capitelli, C. S., Lopes, C. S., Alves, A. C., Barbiero, J. K., de Oliveira, L. F., da Silva, V. J. D., & Vital, M. A. B. F. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.8182 · Cited by 36
Additive amelioration of ALS by co‐targeting independent pathogenic mechanisms
Frakes, A. E., Braun, L., Ferraiuolo, L., Guttridge, D. C., & Kaspar, B. K. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.375 · Cited by 36
Rescue of Rat Anterior Horn Neurons after Spinal Cord Injury by Retrograde Transfection of Adenovirus Vector Carrying Brain-Derived Neurotrophic Factor Gene
Nakajima, H., Uchida, K., Kobayashi, S., Inukai, T., Horiuchi, Y., Yayama, T., Sato, R., & Baba, H. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0004 · Cited by 35
A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting P hase I human trials
Chen, B. K., Staff, N. P., Knight, A. M., Nesbitt, J. J., Butler, G. W., Padley, D. J., Parisi, J. E., Dietz, A. B., & Windebank, A. J. (2014) · Transfusion · doi:10.1111/trf.12938 · Cited by 33
Self-citation
Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice
Narai, H., Nagano, I., Ilieva, H., Shiote, M., Nagata, T., Hayashi, T., Shoji, M., & Abe, K. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20668 · Cited by 33
Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy
Rockenstein, E. M., Ubhi, K. K., Inglis, C. A., Mante, M., Patrick, C., Adame, A., & Masliah, E. (2012) · Neuroreport · doi:10.1097/wnr.0b013e3283509842 · Cited by 31
The Effect of Lentivirus-Mediated PSPN Genetic Engineering Bone Marrow Mesenchymal Stem Cells on Parkinson’s Disease Rat Model
Yin, X., Xu, H., Jiang, Y., Deng, W., Wu, Z., Xiang, H., Sun, P., & Xie, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105118 · Cited by 23
Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration
Watabe, K., Hayashi, Y., & Kawazoe, Y. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00609.x · Cited by 22
Improved dopamine transporter binding activity after bone marrow mesenchymal stem cell transplantation in a rat model of Parkinson’s disease: small animal positron emission tomography study with F-18 FP-CIT
Park, B.-N., Kim, J., Lee, K., Park, S. H., & An, Y. (2014) · European Radiology · doi:10.1007/s00330-014-3549-3 · Cited by 22
Co‐administration of IGF‐I and glycosaminoglycans greatly delays motor neurone disease and affects IGF‐I expression in the wobbler mouse: a long‐term study
Gorio, A., Lesma, E. A., Madaschi, L., & Giulio, A. M. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00830.x · Cited by 20
Dopaminergic Induction of Umbilical Cord Mesenchymal Stem Cells by Conditioned Medium of Choroid Plexus Epithelial Cells Reduces Apomorphine-Induced Rotation in Parkinsonian Rats.
Aliaghaei, A., Gardaneh, M., Maghsoudi, N., Salehinejad, P., & Gharib, E. (2016) · PubMed · Cited by 20
Rare combination of myasthenia and motor neuronopathy, responsive to Msc‐Ntf stem cell therapy
Petrou, P., Argov, A., Lennon, V. A., Gotkine, M., Kassis, I., Vaknin‐Dembinsky, A., Ben‐Hur, T., Offen, D., Abramsky, O., Melamed, E., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.24143 · Cited by 19
Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations
Mei, J., & Niu, C. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2878 · Cited by 15
Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery
Damme, P. V., & Robberecht, W. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.912275 · Cited by 12
Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
Windisch, M., Wolf, H.-J., Hutter‐Paier, B., & Wronski, R. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018343 · Cited by 9

Sorted by citations

Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
“Meanwhile, mesenchymal stem cell transplantation for Parkinson’s disease can significantly improve the daily activities and motor functions of Parkinson’s disease patients without side effects, as well as being safe and reliable.(363,364) In addition, HSC transplantation is a very rapidly and effective clinical treatm…”
Background
A Brief Overview of Global Trends in MSC-Based Cell Therapy
Jovic, D., Yu, Y., Wang, D., Wang, K., Li, H., Xu, F., Liu, C., Liu, J., & Luo, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10369-1 · Cited by 305
Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics
Wang, S., Lei, B., Zhang, E., Gong, P., Gu, J., He, L., Han, L., & Yuan, Z. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s355366 · Cited by 180
Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy
Zhou, X., Deng, X., Liu, M., He, M., Long, W., Xu, Z., Zhang, K., Liu, T., So, K., Fu, Q., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.03.033 · Cited by 160
Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis
Wei, H., Xu, Y., Chen, Q., Chen, H., Zhu, X., & Li, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2490-4 · Cited by 152

See all 150

Authors: Staff, N. P., Jones, D. T., & Singer, W.
Affiliations: Mayo Clinic (US)
Corresponding author: Staff, Nathan P.
ORCID: Staff, Nathan P.
Jones, David T.
Singer, Wolfgang
Venue: Mayo Clinic Proceedings
Publisher: Elsevier BV
Published: 2019-05
Volume: 94
Issue: 5
Pages: 892-905
ISSN: 0025-6196 (ISSN-L)
DOI: 10.1016/j.mayocp.2019.01.001
PMC: PMC6643282
OpenAlex: W2943517835
Cited by: 150
References: 193
Citations by year: 2026: 10 · 2025: 7 · 2024: 18 · 2023: 38 · 2022: 26 · 2021: 26 · 2020: 23 · 2019: 2
FWCI: 2.34
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (am, 365 d)
Locations: Mayo Clinic Proceedings (acceptedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Food and Drug Administration (R01 FD004789)
National Cancer Institute (R01CA211887)
National Institute of Neurological Disorders and Stroke (U54NS065736, R01NS092625)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: mesenchymal stem cells, neurodegenerative diseases, amyotrophic lateral sclerosis, multiple system atrophy, Parkinson's disease, Alzheimer's disease, growth factor secretion, exosomes, neuroinflammation
MeSH terms: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Clinical Trials as Topic, Humans, Parkinson Disease, Multiple System Atrophy, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks